Résultats de la recherche
10
Tout
Rechercher les filtres
Organisation
Enovis Corporation
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
25 mars 2025 08h00 HE
|
Enovis Corporation
WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portfolio of foot and ankle solutions at this year’s...
Enovis to Participate in Upcoming Investor Conferences
05 mars 2025 16h05 HE
|
Enovis Corporation
Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Fourth Quarter and Full Year 2024 Results
26 févr. 2025 06h01 HE
|
Enovis Corporation
Continued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter Reconstructive sales grew 59% year-over-year on a...
Enovis Announces Planned CEO Succession Process
26 févr. 2025 06h00 HE
|
Enovis Corporation
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has...
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
29 janv. 2025 07h00 HE
|
Enovis Corporation
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis™ Announces Leadership Change to International Surgical Business
17 janv. 2025 06h00 HE
|
Enovis Corporation
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr....
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
06 janv. 2025 16h15 HE
|
Enovis Corporation
Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with...
Enovis to Participate in Upcoming Investor Conferences
18 nov. 2024 16h10 HE
|
Enovis Corporation
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will...
Enovis Announces Third Quarter 2024 Results
06 nov. 2024 06h00 HE
|
Enovis Corporation
Continued commercial momentum with third-quarter sales growth of 21% on a reported basis and strong adjusted EBITDA margin expansionReconstructive sales grew 57% Y/Y on a reported basis and 9%...
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
10 oct. 2024 07h00 HE
|
Enovis Corporation
Wilmington, DE, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...